ULTA

Ulta Beauty, Inc. NASDAQ

Consumer Cyclical ·Specialty Retail ·US · ulta.com

$531.95

After hrs $525.69 +1.48%

Mkt Cap $23.9B

52w Low $386.00 44.4% of range 52w High $714.97

50d MA $580.13 200d MA $566.72

P/E (TTM) 20.7x

EV/EBITDA 16.6x

P/B 8.5x

Debt/Equity 0.8x

ROE 41.1%

P/FCF 27.2x

RSI (14) —

ATR (14) —

Beta 0.95

50d MA $580.13

200d MA $566.72

Avg Volume 695.2K

About

Ulta Beauty, Inc. operates as a retailer of beauty products in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; professional hair products; salon services, including hair, skin, makeup, and brow services; and nail services. It also provides its private label products, such as the Ulta Beauty Collec…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Mar 12, 2026	AMC	8.10	8.01	-1.1%	624.70	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%	-15.7%	—
Dec 4, 2025	AMC	4.61	5.14	+11.5%	533.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%	+18.2%	—
Aug 28, 2025	AMC	5.10	5.78	+13.3%	530.63	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%	+4.3%	—
May 29, 2025	AMC	5.81	6.70	+15.3%	421.79	+11.0%	+11.8%	+12.8%	+12.2%	+10.4%	+10.7%	+10.9%	—
Mar 13, 2025	AMC	7.13	8.46	+18.7%	314.47	+8.8%	+13.7%	+13.5%	+9.3%	+9.3%	+8.4%	+16.5%	—
Dec 5, 2024	AMC	4.53	5.14	+13.5%	392.87	+9.0%	+9.0%	+6.4%	+4.8%	+9.5%	+7.9%	+9.8%	—
Aug 29, 2024	AMC	5.46	5.30	-2.9%	367.58	-6.4%	-4.0%	-2.4%	-2.1%	-1.0%	+0.0%	+5.9%	—
May 30, 2024	AMC	6.24	6.47	+3.7%	385.58	+9.2%	+2.5%	+1.1%	+1.0%	+0.4%	-0.2%	-0.3%	—
Mar 14, 2024	AMC	7.53	8.08	+7.3%	565.44	-10.9%	-5.2%	-5.9%	-6.4%	-7.3%	-7.4%	-23.4%	—
Nov 30, 2023	AMC	4.95	5.07	+2.4%	425.99	+11.6%	+10.8%	+14.3%	+13.0%	+16.1%	+15.0%	+14.2%	—
Aug 24, 2023	AMC	5.85	6.02	+2.9%	422.74	+0.6%	-3.7%	-2.8%	-1.8%	+0.0%	-1.8%	-5.8%	—
May 25, 2023	AMC	6.87	6.88	+0.1%	485.12	-10.1%	-13.4%	-16.2%	-15.5%	-16.8%	-12.9%	-4.4%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	Jefferies	Upgrade	Hold → Buy	—	$553.36	$559.00	+1.0%	+3.4%	+3.0%	+1.9%	+2.0%	+0.9%
Apr 14	DA Davidson	Maintains	Buy → Buy	—	$526.76	$530.63	+0.7%	+1.2%	+2.4%	+2.4%	+5.0%	+8.6%
Mar 13	Morgan Stanley	Maintains	Overweight → Overweight	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	Piper Sandler	Maintains	Overweight → Overweight	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	JP Morgan	Maintains	Overweight → Overweight	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	Wells Fargo	Maintains	Underweight → Underweight	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	Oppenheimer	Maintains	Outperform → Outperform	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	Canaccord Genuity	Maintains	Buy → Buy	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 13	TD Cowen	Maintains	Buy → Buy	—	$624.70	$566.28	-9.4%	-14.2%	-17.3%	-16.3%	-16.7%	-14.5%
Mar 11	Evercore ISI	Maintains	Outperform → Outperform	—	$647.23	$646.29	-0.1%	+0.8%	-3.5%	-17.2%	-20.2%	-19.2%
Mar 10	Canaccord Genuity	Maintains	Buy → Buy	—	$642.22	$635.57	-1.0%	+0.8%	+1.6%	-2.7%	-16.6%	-19.5%
Mar 9	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$646.34	$633.28	-2.0%	-0.6%	+0.1%	+1.0%	-3.3%	-17.1%
Mar 9	Wells Fargo	Maintains	Underweight → Underweight	—	$646.34	$633.28	-2.0%	-0.6%	+0.1%	+1.0%	-3.3%	-17.1%
Mar 9	Barclays	Maintains	Overweight → Overweight	—	$646.34	$633.28	-2.0%	-0.6%	+0.1%	+1.0%	-3.3%	-17.1%
Jan 21	TD Cowen	Maintains	Buy → Buy	—	$675.62	$684.39	+1.3%	+1.2%	+0.9%	+1.6%	-2.1%	-3.6%
Jan 21	Raymond James	Upgrade	Outperform → Strong Buy	—	$675.62	$684.39	+1.3%	+1.2%	+0.9%	+1.6%	-2.1%	-3.6%
Jan 20	Oppenheimer	Maintains	Outperform → Outperform	—	$663.48	$662.79	-0.1%	+1.8%	+3.0%	+2.7%	+3.4%	-0.3%
Jan 15	Morgan Stanley	Maintains	Overweight → Overweight	—	$663.85	$665.16	+0.2%	+0.2%	-0.1%	+1.8%	+3.0%	+2.7%
Jan 8	BofA Securities	Maintains	Neutral → Neutral	—	$655.36	$651.79	-0.5%	+0.3%	+1.7%	+0.9%	+1.4%	+1.3%
Jan 7	UBS	Maintains	Buy → Buy	—	$650.06	$649.87	-0.0%	+0.8%	+1.1%	+2.5%	+1.8%	+2.3%
Jan 2	Argus	Maintains	Buy → Buy	—	$605.01	$606.12	+0.2%	+2.5%	+4.3%	+7.4%	+8.3%	+8.7%
Dec 10	Oppenheimer	Maintains	Outperform → Outperform	—	$602.97	$603.05	+0.0%	-0.4%	-1.6%	-0.2%	-2.0%	-2.3%
Dec 8	TD Cowen	Upgrade	Hold → Buy	—	$601.50	$611.84	+1.7%	-2.0%	+0.2%	-0.1%	-1.3%	+0.0%
Dec 8	Morgan Stanley	Maintains	Overweight → Overweight	—	$601.50	$611.84	+1.7%	-2.0%	+0.2%	-0.1%	-1.3%	+0.0%
Dec 5	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	Guggenheim	Maintains	Neutral → Neutral	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	Canaccord Genuity	Maintains	Buy → Buy	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	Piper Sandler	Maintains	Overweight → Overweight	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	JP Morgan	Maintains	Overweight → Overweight	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	UBS	Maintains	Buy → Buy	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	Baird	Maintains	Outperform → Outperform	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	Oppenheimer	Maintains	Outperform → Outperform	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	Evercore ISI	Maintains	Outperform → Outperform	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 5	DA Davidson	Maintains	Buy → Buy	—	$533.95	$578.95	+8.4%	+12.7%	+10.4%	+12.9%	+12.5%	+11.1%
Dec 1	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$538.83	$538.39	-0.1%	+1.6%	+1.7%	+1.1%	-0.9%	+11.6%
Dec 1	JP Morgan	Maintains	Overweight → Overweight	—	$538.83	$538.39	-0.1%	+1.6%	+1.7%	+1.1%	-0.9%	+11.6%
Oct 17	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$537.29	$536.12	-0.2%	-0.7%	-2.5%	-2.1%	-3.3%	-2.4%
Oct 16	Wells Fargo	Maintains	Underweight → Underweight	—	$538.49	$538.89	+0.1%	-0.2%	-0.9%	-2.7%	-2.3%	-3.6%
Oct 10	Canaccord Genuity	Maintains	Buy → Buy	—	$561.15	$564.72	+0.6%	-2.1%	-3.2%	-3.6%	-4.0%	-4.3%
Sep 25	Argus	Upgrade	Hold → Buy	—	$535.61	$539.37	+0.7%	+0.7%	+3.1%	+3.4%	+2.1%	+3.8%
Sep 8	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$514.86	$518.95	+0.8%	+1.0%	-0.2%	+0.1%	+1.4%	-0.0%
Sep 2	Barclays	Maintains	Overweight → Overweight	—	$492.73	$491.26	-0.3%	+8.1%	+7.8%	+7.5%	+4.5%	+5.5%
Aug 29	Telsey Advisory Group	Maintains	Outperform → Outperform	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%
Aug 29	Baird	Maintains	Outperform → Outperform	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%
Aug 29	UBS	Maintains	Buy → Buy	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%
Aug 29	Goldman Sachs	Maintains	Buy → Buy	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%
Aug 29	BofA Securities	Maintains	Neutral → Neutral	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%
Aug 29	Evercore ISI	Maintains	Outperform → Outperform	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%
Aug 29	Morgan Stanley	Maintains	Overweight → Overweight	—	$530.63	$526.85	-0.7%	-7.1%	+0.4%	+0.1%	-0.2%	-3.0%

Recent Filings

Cramer's Stop Trading: Ulta Beauty

Apr 20

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Unable to provide meaningful analysis without specific disclosure content; the filing summary only shows boilerplate language and references a press release dated March 24, 2026—review the actual press release for material information.

Mar 24

8-K

Unknown — 8-K Filing

Ulta Beauty's fiscal 2026 guidance of 6-7% sales growth with 9.4-11.4% EPS growth, backed by share repurchases, signals margin expansion and shareholder returns despite modest top-line growth.

Mar 12

Data updated apr 27, 2026 6:44am · Source: massive.com